CNC vs MIST · P/E 8.4, rev $163.07B vs $160.6M cap
Centene Corp (CNC) versus Milestone Pharmaceuticals Inc (MIST) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
MIST does not have a complete income-statement cache yet.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. MIST currently screens at market cap $160.6M.
Not investment advice. Open the CNC and MIST stock pages for the full models.
Not investment advice.